[1] FELICE V D, QUIGLEY E M, SULLIVAN A M, et al. Microbiota-Gut-Brain signalling in Parkinson’s disease: Implications for Non-Motor Symptoms[J]. Parkinsonism Relat Disord, 2016,27:1-8. [2] HU X, WANG T, JIN F. Alzheimer’s disease and gut microbiota[J]. Sci China Life Sci, 2016, 59(10):1006-1023. [3] KESHAVARZIAN A, GREEN S J, ENGEN P A, et al. Colonic bacterial composition in Parkinson’s disease[J]. Mov Disord, 2015, 30(10):1351-1360. [4] SÁNCHEZ B, DELGADO S, BLANCO-MÍGUEZ A, et al. Probiotics, gut microbiota and their influence on host health and disease[J]. Mol Nutr Food Res, 2016, 68(9):76-89. [5] KIM J S, SUNG H Y. Gastrointestinal autonomic dysfunction in patients with Parkinson’s disease[J]. J Mov Disord, 2015, 20(11):1151-1159. [6] SHANNON K M, KESHAVARZIAN A, DODIYA H B, et al. Is alpha-synuclein in the colon a biomarker for premotor Parkinson’s disease? Evidence from 3 cases[J]. Mov Disord, 2017, 27(6):50-60. [7] SORET R, CHEVALIER J, COPPET P D, et al. Short-chain fatty acids regulate the enteric neurons and control gastrointestinal motility in rats[J]. Gastroenterology, 2018, 138(5):1772-1782. [9] 李琳琳, 杨浩, 王烨.肠道菌群代谢产物短链脂肪酸与2型糖尿病的关系[J]. 新疆医科大学学报, 2017, 40(12):1517-1521. [9] VASCONCELLOS L F R, PEREIRA J S. Parkinson’s disease dementia: Diagnostic criteria and risk factor review[J]. J Clin Exp Neuropsychol, 2015,37(9):988-993. [10] 杨浩, 王烨, 王蟾月, 等.新疆维吾尔族2型糖尿病人群肠道中Faecalibacterium prausnitzii的定量研究[J].中国微生态学杂志,2017, 29(9):1005-1008. [11] BALAMURUGAN R,JANARDHAN H P,GEORGE S,et al.Molecular studies of fecal anaerobic commensal bacteria in acute diarrhea in children[J].J Pediatr Gastroenterol Nutr,2008,46(5):514-519. [12] 刘利.新疆伊犁地区学龄儿童肠道菌属检测及意义[D].新疆医科大学,2014. [13] 杨晓庆. 小鼠肠道菌群代谢产物与糖尿病的相关性研究[D].新疆医科大学,2010. [14] LI W, WU X, HU X, et al. Structural changes of gut microbiota in Parkinson’s disease and its correlation with clinical features[J]. Sci China Life Sci, 2017, 60(11):1223-1233. [15] QIAN Y, YANG X, XU S, et al. Alteration of the fecal microbiota in Chinese patients with Parkinson's disease[J]. Brain Behav Immun, 2018,70(16):194-202. [16] SHERWIN E, SANDHU K V, DINAN T G, et al. May the force be with you: The light and dark sides of the Microbiota-Gut-Brain Axis in Neuropsychiatry[J]. CNS Drugs, 2016, 30(11):1019-1041. [17] UNGER M M, SPIEGEL J, DILLMANN K U, et al. Short chain fatty acids and gut microbiota differ between patients with Parkinson’s disease and age-matched controls[J]. Parkinsonism Relat Disord, 2016, 32:66-72. [18] ZHANG H, WU J, SHEN F F, et al. Activated Schwann cells and increased inflammatory cytokines IL-1β, IL-6, and TNF-α in patients’ sural nerve are lack of tight relationship with specific sensory disturbances in Parkinson’s disease[J].CNS Neurosci Ther, 2020,26(5): 518-526. |